Sinus Dynamics Reaches Milestone with Treatment of Nasal Allergy, Sinus Infection, Acute and Chronic Sinusitis Treating 25,000th Patient

A New Asthma Treatment Introduced by Russian Scientists

Getting the Most out of Dry Powder Inhaler for Asthma and COPD

New York, NY (PRWEB) April 3, 2008 -- Proper technique is the key to benefiting from dry powder inhalers (DPIs) that treat chronic obstructive pulmonary disease (COPD) and asthma. But data presented...

Barlow Respiratory Hospital Receives $500,000 QueensCare Grant for Life-Saving Patient Care

Los Angeles, CA (PRWEB) December 3, 2007 -- City of Los Angeles residents who are in need of critical pulmonary rehabilitation services but can't afford them now have new hope. Barlow...

Press Release

Frimley, UK, August 11th, 2010 – Onbrez Breezhaler (indacaterol), the first 24-hour long-acting beta agonist (LABA) for the treatment of Chronic Obstructive Pulmonary Disease (COPD) in adults, has been launched today by Novartis Pharmaceuticals UK Ltd. This once daily medication is the first new treatment for COPD available in the UK for eight years.